Envoy Medical, Inc.
$0.7
▲
6.03%
2026-04-21 06:09:00
www.envoymedical.com
NCM: COCH
Explore Envoy Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$54.48 M
Current Price
$0.7
52W High / Low
$1.91 / $0.36
Stock P/E
—
Book Value
$-0.41
Dividend Yield
3.34%
ROCE
741.34%
ROE
155.22%
Face Value
—
EPS
$-1.23
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
43
Beta
2.05
Debt / Equity
-0.08
Current Ratio
0.54
Quick Ratio
0.41
Forward P/E
-2.04
Price / Sales
195.23
Enterprise Value
$44.23 M
EV / EBITDA
-2.03
EV / Revenue
183.53
Rating
Strong Buy
Target Price
$2.5
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 2. | Vivos Therapeutics, Inc. | $1.01 | — | $13.14 M | — | -108.39% | -3.35% | $7.95 / $0.96 | $0.31 |
| 3. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 4. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
| 5. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
| 6. | CeriBell, Inc. | $21.13 | — | $797.62 M | — | -33.07% | -30.83% | $24.33 / $10.85 | $4.14 |
| 7. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.07 M | 0.04 M | 0.08 M | 0.05 M | 0.04 M | — |
| Operating Profit | -6.38 M | -5.71 M | -5.07 M | -5.11 M | -4.52 M | — |
| Net Profit | -6.59 M | -6.48 M | -5.69 M | -5 M | -4.62 M | — |
| EPS in Rs | -0.09 | -0.08 | -0.07 | -0.07 | -0.06 | -0.39 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.24 M | 0.23 M | 0.32 M | 0.24 M |
| Operating Profit | -22.27 M | -19.26 M | -18.36 M | -8.71 M |
| Net Profit | -23.76 M | -20.8 M | -29.92 M | -15.92 M |
| EPS in Rs | -0.31 | -0.27 | -0.39 | -0.21 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 8.56 M | 11.54 M | 8.27 M | 2.56 M |
| Total Liabilities | 20.32 M | 30.38 M | 10.05 M | 38.75 M |
| Equity | -11.77 M | -18.84 M | -1.78 M | -36.2 M |
| Current Assets | 6.28 M | 8.9 M | 7.46 M | 1.65 M |
| Current Liabilities | 11.56 M | 7.54 M | 7.29 M | 2.52 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -18.2 M | -17.95 M | -17.09 M | -8.8 M |
| Investing CF | -0.18 M | -0.98 M | -0.15 M | -0.22 M |
| Financing CF | 16.63 M | 20.2 M | 21.28 M | 8.09 M |
| Free CF | -18.38 M | -18.93 M | -17.24 M | -9.02 M |
| Capex | -0.18 M | -0.98 M | -0.15 M | -0.22 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -28.8% | 33.33% | — | — |
| Earnings Growth % | 30.5% | -87.92% | — | — |
| Profit Margin % | -9242.22% | -9468.99% | -6718.57% | — |
| Operating Margin % | -8558.22% | -5809.81% | -3673.42% | — |
| Gross Margin % | -229.78% | -149.68% | -110.13% | — |
| EBITDA Margin % | -8802.67% | -9426.9% | -3641.77% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.